Recombinant Human ApoH (C-6His)

Description

EnkiLife provides the Recombinant Human ApoH (C-6His) protein,aslo know as Beta-2-Glycoprotein 1,APC inhibitor,Activated Protein C-Binding Protein,Anticardiolipin Cofactor,Apolipoprotein H,Apo-H,Beta-2-Glycoprotein I,B2GPIBeta(2)GPI,APOH,B2G1, which features high purity, high activity, and high stability. It can be applied in scientific research, biopharmaceuticals, and other fields.Purity:Greater than 95% as determined by reducing SDS-PAGE;Endotoxin Level:<1 EU/µg as determined by LAL test.;Construction:Recombinant Human Apolipoprotein H is produced by our Mammalian expression system and the target gene encoding Gly20-Cys345 is expressed with a 6His tag at the C-terminus.Accession:P02749. Expression Host:Human Cells.Species:Human.Predicted Molecular Mass:37.29 KDa. Background:Apolipoprotein H (ApoH) is a 50 kDa variably glycosylated member of the complement control superfamily of proteins. Human ApoH is a major phospholipid binding protein and an important component to measure in the assessment of anti-phospholipid syndrome. Hepatocyte-derived ApoH binds to negatively charged phospholipids . It circulates as a component of lipoprotein particles and as a lipid-free serum protein. Human ApoH is also more specific than anti-cardiolipin antibodies and its presence correlates better with thrombotic risk. Mature human ApoH shares 76% and 82% aa sequence identity with mouse and rat ApoH.